Bio Protocol's inaugural Launchpad project, Aubrai, has been oversubscribed by 5.4 times, according to an announcement on the X platform. The high demand reflects strong investor interest in the project. Following the launch event, Aubrai tokens will soon be available for secondary trading, providing further opportunities for market participants.